title: Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target?
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, University of Cincinnati, Cincinnati VA Medical Center, Cincinnati, Ohio, USA. dalessd@ucmail.uc.edu
authors.forename: David A
authors.initials: DA
authors.lastname: D'Alessio
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005934:Glucagon / Q000378:metabolism*; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000378:metabolism*
chemical_list: D007328:Insulin; D052216:Glucagon-Like Peptide 1; D005934:Glucagon